Searched for
US PHARMA LOBBY GROUPS
Come inside Iran's World Cup hotel in Mexico, where fans turn up to cheerDespite political hurdles and visa issues forcing Iran's World Cup team to relocate to Tijuana, Mexico, a jubilant atmosphere surrounds the...- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- Did Joe Biden’s ex-medical advisor Fauci fund China’s Wuhan Lab research behind Covid-19 outbreak? Tulsi Gabbard’s final act with ‘never-before-seen’ documents reveals explosive claimsOutgoing Director of National Intelligence Tulsi Gabbard has leveled serious accusations against Anthony Fauci, alleging he funneled US tax...
- USFDA concludes inspection at Jubilant HollisterStier's Spokane plant with 8 observationsJubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washingt...
- Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...
- Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...
- Meta lobbies Congress for protection from child-harm lawsuitsIf adopted by lawmakers and passed into law as part of the Kids Online Safety Act (KOSA) under consideration in the U.S. Senate, such a pro...
- Trump’s copper tariff decision hangs over global metal marketThe global copper market is on edge as President Trump weighs imposing tariffs on refined copper imports. A decision, expected soon, could ...
- US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisitionThe U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a cond...
- The 'Indo' exit: Pentagon's PACOM reset raises questions about India's place in Trump's Asia calculusWashington's decision to rename the US Indo-Pacific Command back to Pacific Command has sparked debate over India's strategic importance. D...
- Telegram stops working for existing users in India but operational on VPNTelegram access is temporarily blocked in India for existing users. This action aims to prevent paper leaks for the upcoming NEET-UG 2026 r...
- Telegram CEO claims Reliance, WhatsApp's role behind efforts to ban company's app in IndiaTelegram CEO Pavel Durov accuses Reliance Group and WhatsApp of lobbying to ban his app in India. He also claims Reliance is disrupting Tel...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
- Light at the end of the tunnel? Gautam Shah sees Nifty eyeing 25,500, bets on smallcaps, pharma and Adani stocksIndian equities are nearing a crucial turning point, with market veteran Gautam Shah suggesting a shift in focus beyond benchmark indices. ...
- 'Start your engines'? Shippers wary on Hormuz reopeningShipping groups are hesitant to resume sailing through the Strait of Hormuz. An agreement between the US and Iran promises its reopening. H...
- 'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautiousGlobal challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
Load More
